- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02306252
The CARE Program: CAncer REhabilitation Pilot Study for Older Adults (CARE Program)
September 11, 2017 updated by: UNC Lineberger Comprehensive Cancer Center
LCCC 1409: The CARE Program: CAncer REhabilitation Pilot Study for Older Adults
The CARE Program is a randomized trial of a cancer rehabilitation program designed to help older cancer patients who have shown to have a loss of function.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a prospective, two-arm, single-center randomized controlled pilot trial of a cancer rehabilitation program for older adults, titled the 'CARE program,' which is designed to maintain and/or improve functional status and quality of life in older adults diagnosed with cancer.
Adults aged 65 years and older with cancer will be screened with a Geriatric Assessment (GA) for eligibility.
Although breast cancer patients will be eligible, this study will focus primarily on other types of cancers.
Adults with at least one functional deficit --defined as impairment in ability to perform activities of daily living or instrumental activities of daily living, cognitive decline or balance -- will be randomized to either the intervention (CARE program) or to the control arm (Supportive care services information only).
Both arms will receive a brochure about the supportive care program to provide patients who we've identified as having deficits with information about auxiliary services available and because the intent is to limit the difference between the groups.
We hypothesize that patients who participate in the CARE program will maintain or improve functional status and quality of life when compared to supportive care services information only.
Study Type
Interventional
Enrollment (Actual)
67
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- University of North Carolina
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Aged 65 years or older
- Has an outpatient appointment within UNC Chapel Hill Lineberger Comprehensive Cancer Center
- Diagnosis of cancer within last two years.
- Has a life expectancy of 12 months or longer. All cancer types are included.
- English speaking
- Willing to complete the UNC GA
- Has at least one functional deficit as defined by GA screen
- Understands study design, risks, and benefits and have signed informed consent
- Willing to be randomized into either study arm
- Ability to safely participate in outpatient rehabilitation program
Exclusion Criteria:
- Unable to safely participate in outpatient rehabilitation.
- Currently receiving rehabilitation.
- Any participant who has urologic cancer or is enrolled in a competing trial.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: CARE Intervention
This group will be contacted to make an appointment for outpatient Occupational and Physical therapy.
The therapist will determine the type, frequency and length of treatment.
Follow up phone calls will be made to ensure appointments are made, kept and rescheduled as needed.
|
OT and PT will be arranged for the subject and conducted in a manner as determined by the therapist.
|
No Intervention: CARE Control
Patients randomized to this arm will receive contact information and a brochure outlining the services available within the supportive care program.
The study coordinator will provide the information based on their results and assist the patient with contacting the program if desired.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To measure the change in Nottingham Extended Activities of Daily Living (NEADL) score from baseline to three months.
Time Frame: 3 months
|
Compare the change in NEADL scores from baseline to 3 months between patients who receive the CARE program (intervention) and those in the control arm.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To measure the change in Activities of Daily Living from Baseline and 2 months
Time Frame: 2 months
|
As measured by the Geriatric Assessment
|
2 months
|
To measure the change in Activities of Daily Living from Baseline and 3 months
Time Frame: 3 months
|
As measured by the Geriatric Assessment
|
3 months
|
To measure the change in physical health from Baseline and 3 months
Time Frame: 3 months
|
As measured by the Geriatric Assessment
|
3 months
|
To measure the change in physical health from Baseline and 2 months
Time Frame: 2 months
|
As measured by the Geriatric Assessment
|
2 months
|
To measure the change in quality of life from Baseline and 2 months
Time Frame: 2 months
|
As measured by the PROMIS assessment
|
2 months
|
To measure the change in quality of life from Baseline and 3 months
Time Frame: 3 months
|
As measured by the PROMIS assessment
|
3 months
|
To measure the change in internalized occupational possibilities from Baseline and 3 months
Time Frame: 3 months
|
As measured by the Possibilities for Activity Scale (PActS)
|
3 months
|
To measure the change in internalized occupational possibilities from Baseline and 2 months
Time Frame: 2 months
|
As measured by the Possibilities for Activity Scale (PActS)
|
2 months
|
To measure the change in cognitive function from Baseline and 2 months
Time Frame: 2 months
|
As measured by the Blessed Memory Orientation Concentration test
|
2 months
|
To measure the change in cognitive function from Baseline and 3 months
Time Frame: 3 months
|
As measured by the Blessed Memory Orientation Concentration test
|
3 months
|
To measure the feasibility of the CARE Program
Time Frame: 3 months
|
To describe the feasibility of the CARE program by reporting enrollment and retention as defined by (1) percent eligible who agree to participate (2) percent in each group that completed follow-up measures at 2 and 3 months and (3) percent of patients in CARE program who go to 70% of appointments.
|
3 months
|
To measure the change in balance over the course of the study
Time Frame: 3 months
|
Intervention Group Only: As measured by the Berg Balance Scale
|
3 months
|
To measure the change in upper extremity use and ability over the course of the study
Time Frame: 3 months
|
Intervention Group Only: As measured by the Disability of the Arm, Shoulder and Hand scale
|
3 months
|
To measure the change in cognition over the course of the study
Time Frame: 3 months
|
Intervention Group Only: As measured by the Montreal Cognitive Assessment
|
3 months
|
To measure the change in dynamic gait ability over the course of the study
Time Frame: 3 months
|
Intervention Group Only: As measured by the Dynamic Gait Index
|
3 months
|
To measure satisfaction with the CARE Program
Time Frame: 3 months
|
To evaluate the program a short interview will be completed with CARE team to determine what worked well, what didn't and suggested changes/improvements for CARE program after completion of project.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Mackenzi Pergolotti, PhD, Colorado State University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2014
Primary Completion (Actual)
March 1, 2017
Study Completion (Actual)
March 1, 2017
Study Registration Dates
First Submitted
December 1, 2014
First Submitted That Met QC Criteria
December 2, 2014
First Posted (Estimate)
December 3, 2014
Study Record Updates
Last Update Posted (Actual)
September 12, 2017
Last Update Submitted That Met QC Criteria
September 11, 2017
Last Verified
September 1, 2017
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- LCCC1409
- 14-1159 (Other Identifier: University of North Carolina IRB)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
University of Michigan Rogel Cancer CenterRecruitingCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterHyundai Hope On WheelsRecruitingCancer | Pediatric Cancer | Survivorship | Cancer MetastaticUnited States
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Breast Cancer | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage... and other conditionsUnited States
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Hepatobiliary CancerUnited States
-
Johns Hopkins UniversityNational Cancer Institute (NCI); National Institute on Minority Health and...Enrolling by invitationCancer | Advanced Cancer | End Stage Cancer | MalignancyUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Case Comprehensive Cancer CenterCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer and other conditionsUnited States
Clinical Trials on Occupational and Physical Therapy
-
University Hospital Inselspital, BerneCompleted
-
University of ArizonaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedCerebral PalsyUnited States
-
Zuyd University of Applied SciencesMaastricht UniversityUnknown
-
Ruhr University of BochumDeutsche Gesetzliche Unfallversicherung (DGUV)UnknownPhantom Limb PainGermany
-
Washington University School of MedicineEnrolling by invitationMotor Neuron Disease | Amyotrophic Lateral Sclerosis | Lou Gehrig Disease | Familial Amyotrophic Lateral Sclerosis | Motor Neuron Disease, FamilialUnited States
-
UNC Lineberger Comprehensive Cancer CenterRecruitingBone Marrow Transplantation | Bone Marrow DiseaseUnited States
-
Associação de Assistência a Criança DeficienteCompletedAcquired Brain Injury | Poliomyelitis | Spinal Cord Injury
-
Cairo UniversityCompletedSports Physical TherapyEgypt
-
University of Sao Paulo General HospitalConselho Nacional de Desenvolvimento Científico e TecnológicoTerminated
-
Cairo UniversityRecruitingSports Physical TherapyEgypt